EXECUTIVE EMPLOYMENT AGREEMENTRestrictive Covenant Agreement • August 6th, 2024 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Maine
THIS THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made as of August 2, 2024 (the “Effective Date”) by and between IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), and Jonathan (Jay) Mazelsky (the “Executive”) and amends and restates in its entirety the Second Amended and Restated Employment Agreement by and between the Company and the Executive dated as of October 23, 2019.
Employee Stock Option AgreementEmployee Stock Option Agreement • August 6th, 2024 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
SUSPENSION OF RIGHTS AGREEMENTSuspension of Rights Agreement • August 6th, 2024 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
Reference is made to that certain Fourth Amended and Restated Credit Agreement, dated as of December 9, 2021, by and among the Borrowers, JPMorgan Chase Bank, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”), JPMorgan Chase Bank, N.A., Toronto Branch, as Toronto Agent (in such capacity, the “Toronto Agent”) and the Lenders from time to time party thereto (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”).
FORM OF CHANGE IN CONTROL AGREEMENTChange in Control Agreement • August 6th, 2024 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
THIS CHANGE IN CONTROL AGREEMENT is made as of [ ], 20[ ] (this “Agreement”), by and between IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), and (the “Executive”) [and amends and restates in its entirety the [Amended and Restated] Executive Employment Agreement by and between the Company and the Executive dated as of [ ]].
